Protein/Protein Interactions in the Mammalian Heme Degradation Pathway
暂无分享,去创建一个
E. Zuiderweg | S. Ragsdale | D. Becker | A. M. Spencer | Ireena Bagai | Erik R P Zuiderweg | Stephen W Ragsdale | Donald F Becker | Ireena Bagai | Andrea L M Spencer
[1] M. Maines,et al. Nuclear localization of biliverdin reductase in the rat kidney: response to nephrotoxins that induce heme oxygenase-1. , 2001, The Journal of pharmacology and experimental therapeutics.
[2] P. Ortiz de Montellano,et al. Role of Cysteine Residues in Heme Binding to Human Heme Oxygenase-2 Elucidated by Two-dimensional NMR Spectroscopy* , 2012, The Journal of Biological Chemistry.
[3] M. Maines,et al. Site-directed mutagenesis of cysteine residues in biliverdin reductase. Roles in substrate and cofactor binding. , 1994, European journal of biochemistry.
[4] Solomon H. Snyder,et al. Biliverdin reductase: A major physiologic cytoprotectant , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[5] Hideaki Sato,et al. Structural basis for the electron transfer from an open form of NADPH-cytochrome P450 oxidoreductase to heme oxygenase , 2014, Proceedings of the National Academy of Sciences.
[6] H. Kamin,et al. Microsomal triphosphopyridine nucleotide-cytochrome c reductase of liver. , 1962, The Journal of biological chemistry.
[7] P. Ortiz de Montellano,et al. Reaction Intermediates and Single Turnover Rate Constants for the Oxidation of Heme by Human Heme Oxygenase-1* , 2000, The Journal of Biological Chemistry.
[8] Danielson Pb,et al. The cytochrome P450 superfamily: biochemistry, evolution and drug metabolism in humans. , 2002 .
[9] M. Maines,et al. The heme oxygenase system: a regulator of second messenger gases. , 1997, Annual review of pharmacology and toxicology.
[10] B. Masters,et al. Diminished FAD Binding in the Y459H and V492E Antley-Bixler Syndrome Mutants of Human Cytochrome P450 Reductase* , 2006, Journal of Biological Chemistry.
[11] P. B. Crowley,et al. Close encounters of the transient kind: protein interactions in the photosynthetic redox chain investigated by NMR spectroscopy. , 2003, Accounts of chemical research.
[12] Gary Patterson,et al. Physical Chemistry of Macromolecules , 2007 .
[13] J. Roder,et al. Heme oxygenase 2 , 1998 .
[14] S. Ragsdale,et al. Evidence That the Heme Regulatory Motifs in Heme Oxygenase-2 Serve as a Thiol/Disulfide Redox Switch Regulating Heme Binding* , 2007, Journal of Biological Chemistry.
[15] H. Marver,et al. Microsomal heme oxygenase. Characterization of the enzyme. , 1969, The Journal of biological chemistry.
[16] M. Maines,et al. Isolation and characterization of a cDNA from the rat brain that encodes hemoprotein heme oxygenase-3. , 1997, European journal of biochemistry.
[17] M. Moore. Characterization of the enzyme , 1994 .
[18] S. Grzesiek,et al. NMRPipe: A multidimensional spectral processing system based on UNIX pipes , 1995, Journal of biomolecular NMR.
[19] G. Kikuchi,et al. Inability of the NADH‐cytochrome b 5 reductase system to initiate heme degradation yielding biliverdin IXα from the oxygenated form of heme · heme oxygenase complex , 1980, FEBS letters.
[20] M. Maines. The heme oxygenase system: update 2005. , 2005, Antioxidants & redox signaling.
[21] H. Sakamoto,et al. Characterization of rat heme oxygenase-3 gene. Implication of processed pseudogenes derived from heme oxygenase-2 gene. , 2004, Gene.
[22] M. Maines,et al. Human Biliverdin Reductase Is a Leucine Zipper-like DNA-binding Protein and Functions in Transcriptional Activation of Heme Oxygenase-1 by Oxidative Stress* , 2002, The Journal of Biological Chemistry.
[23] M. Busker,et al. Heme Oxygenase Isoforms Differ in Their Subcellular Trafficking during Hypoxia and Are Differentially Modulated by Cytochrome P450 Reductase , 2012, PloS one.
[24] H. Enoch,et al. Cytochrome b5 reduction by NADPH-cytochrome P-450 reductase. , 1979, The Journal of biological chemistry.
[25] L. Otterbein,et al. Carbon Monoxide and the brain: time to rethink the dogma. , 2013, Current pharmaceutical design.
[26] J. Sambrook,et al. Molecular Cloning: A Laboratory Manual , 2001 .
[27] H. Kalbitzer,et al. Protein NMR Spectroscopy. Principles and Practice , 1997 .
[28] M. Maines,et al. Heme oxygenase-2 interaction with metalloporphyrins: function of heme regulatory motifs. , 2001, Antioxidants & redox signaling.
[29] S. Sassa. Why Heme Needs to Be Degraded to Iron, Biliverdin IXα, and Carbon Monoxide? , 2004 .
[30] J. Potts,et al. Recent Developments in Biomolecular NMR , 2012 .
[31] H. Sakamoto,et al. Involvement of NADP(H) in the Interaction between Heme Oxygenase-1 and Cytochrome P450 Reductase* , 2005, Journal of Biological Chemistry.
[32] P. Schuck,et al. Size-distribution analysis of macromolecules by sedimentation velocity ultracentrifugation and lamm equation modeling. , 2000, Biophysical journal.
[33] M. Maines,et al. Human biliverdin reductase is an ERK activator; hBVR is an ERK nuclear transporter and is required for MAPK signaling , 2008, Proceedings of the National Academy of Sciences.
[34] R. Riek,et al. Attenuated T2 relaxation by mutual cancellation of dipole-dipole coupling and chemical shift anisotropy indicates an avenue to NMR structures of very large biological macromolecules in solution. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[35] T. Münzel,et al. Conversion of biliverdin to bilirubin by biliverdin reductase contributes to endothelial cell protection by heme oxygenase-1-evidence for direct and indirect antioxidant actions of bilirubin. , 2010, Journal of molecular and cellular cardiology.
[36] D. Gemsa. MICROSOMAL HEME OXYGENASE , 1981 .
[37] P. Danielson,et al. The cytochrome P450 superfamily: biochemistry, evolution and drug metabolism in humans. , 2002, Current drug metabolism.
[38] A. Palmer,et al. Protein NMR Spectroscopy: principles and practice, 2nd ed. , 2006 .
[39] K. Bloch,et al. Solubilization and partial characterization of rat liver squalene epoxidase. , 1975, The Journal of biological chemistry.
[40] N. Andrews,et al. Iron homeostasis. , 2007, Annual review of physiology.
[41] S. Ryter,et al. CO as a cellular signaling molecule. , 2006, Annual review of pharmacology and toxicology.
[42] Paul M. Jenkins,et al. Heme Regulatory Motifs in Heme Oxygenase-2 Form a Thiol/Disulfide Redox Switch That Responds to the Cellular Redox State* , 2009, The Journal of Biological Chemistry.
[43] M. Maines,et al. Small Interference RNA-mediated Gene Silencing of Human Biliverdin Reductase, but Not That of Heme Oxygenase-1, Attenuates Arsenite-mediated Induction of the Oxygenase and Increases Apoptosis in 293A Kidney Cells* , 2005, Journal of Biological Chemistry.
[44] M. Maines. Carbon Monoxide: An Emerging Regulator of cGMP in the Brain , 1993, Molecular and Cellular Neuroscience.
[45] A. D. McLachlan,et al. Introduction to magnetic resonance : with applications to chemistry and chemical physics , 1967 .
[46] Benveniste,et al. Cytochrome P450 , 1993, Handbook of Experimental Pharmacology.
[47] M. Maines,et al. Purification and characterization of biliverdin reductase from rat liver. , 1981, The Journal of biological chemistry.
[48] S. Snyder,et al. Bilirubin and glutathione have complementary antioxidant and cytoprotective roles , 2009, Proceedings of the National Academy of Sciences.
[49] M. H. Quenouille. NOTES ON BIAS IN ESTIMATION , 1956 .
[50] M. Ikeda-Saito,et al. Heme oxygenase reveals its strategy for catalyzing three successive oxygenation reactions. , 2010, Accounts of chemical research.
[51] P. Hollenberg,et al. Uncovering the role of hydrophobic residues in cytochrome P450-cytochrome P450 reductase interactions. , 2011, Biochemistry.
[52] E. Wood,et al. Data for Biochemical Research, 3rd Edn , 1987 .
[53] A. Hodgson,et al. NADPH Cytochrome P450 Reductase and Its Structural and Functional Domains , 1995 .
[54] M. Maines,et al. Human biliverdin reductase: a member of the insulin receptor substrate family with serine/threonine/tyrosine kinase activity. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[55] D. Nelson,et al. Cytochrome P-450: cytochrome P-450 reductase interactions. , 1989, Drug metabolism reviews.
[56] W. H. Elliott,et al. Data for Biochemical Research , 1986 .
[57] J. Forman-Kay,et al. CFTR regulatory region interacts with NBD1 predominantly via multiple transient helices , 2007, Nature Structural &Molecular Biology.
[58] Julie D. Forman-Kay,et al. Transient structure and dynamics in the disordered c-Myc transactivation domain affect Bin1 binding , 2012, Nucleic acids research.
[59] Cicerone Tudor,et al. Biliverdin reductase is a transporter of haem into the nucleus and is essential for regulation of HO-1 gene expression by haematin. , 2008, The Biochemical journal.
[60] M. Ubbink. The courtship of proteins: Understanding the encounter complex , 2009, FEBS letters.
[61] M. Maines. New insights into biliverdin reductase functions: linking heme metabolism to cell signaling. , 2005, Physiology.
[62] J. Cavanagh. Protein NMR Spectroscopy: Principles and Practice , 1995 .
[63] B. Masters,et al. Measurement of Membrane-Bound Human Heme Oxygenase-1 Activity Using a Chemically Defined Assay System , 2009, Drug Metabolism and Disposition.
[64] G. Phillips,et al. Comparison of Apo- and Heme-bound Crystal Structures of a Truncated Human Heme Oxygenase-2* , 2007, Journal of Biological Chemistry.
[65] H. Zhou,et al. Identification of Histidine 45 as the Axial Heme Iron Ligand of Heme Oxygenase-2* , 1998, The Journal of Biological Chemistry.
[66] H. Sakamoto,et al. Mass spectrometric identification of lysine residues of heme oxygenase-1 that are involved in its interaction with NADPH-cytochrome P450 reductase. , 2008, Biochemical and biophysical research communications.
[67] 31P NMR study of the kinetics of binding of myo-inositol hexakisphosphate to human hemoglobin. Observation of fast-exchange kinetics in high-affinity systems. , 1981, European journal of biochemistry.
[68] M. Maines. The heme oxygenase system: past, present, and future. , 2004, Antioxidants & redox signaling.
[69] P. D. de Montellano,et al. The Binding Sites on Human Heme Oxygenase-1 for Cytochrome P450 Reductase and Biliverdin Reductase* , 2003, Journal of Biological Chemistry.
[70] S. Sassa. Why heme needs to be degraded to iron, biliverdin IXalpha, and carbon monoxide? , 2004, Antioxidants & redox signaling.
[71] R. Mariuzza,et al. Sedimentation velocity analysis of heterogeneous protein-protein interactions: Lamm equation modeling and sedimentation coefficient distributions c(s). , 2005, Biophysical journal.
[72] Kiriko Kaneko,et al. Heme as a magnificent molecule with multiple missions: heme determines its own fate and governs cellular homeostasis. , 2007, The Tohoku journal of experimental medicine.
[73] P. D. de Jong,et al. Ligation-independent cloning of PCR products (LIC-PCR). , 1990, Nucleic acids research.